Synlogic Inc
synlogictx.comWhat Do They Do?
Pursues strategic transactions, including a merger or sale.
10-K for FY2025, filed Mar 12, 2026We are a biopharmaceutical company that previously advanced novel therapeutics to transform the care of serious diseases. We focused on…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 11, 2026
−$543KView ↗
- ▲ +3% (Loss)
- vs −$529K in Q2 FY2025
-
Jul 29, 2026
Synlogic agreed to merge with Caldera
The all-stock merger would place both companies under a new holding company that plans to operate as Caldera Therapeutics.
Sources
8-K, filed Jul 29, 2026
On July 28, 2026, Synlogic, Inc., a Delaware corporation (“Synlogic”), entered into an Agreement and Plan of Merger (the “Merger…View ↗
From drug pipeline to strategic transactions
The earlier report described a clinical and preclinical pipeline of engineered probiotic medicines for metabolic and immune diseases. The latest says the lead trial was discontinued and the company is pursuing strategic transactions, including a merger or sale.
10-K for FY2022, filed Mar 29, 2023 10-K for FY2025, filed Mar 12, 2026We are a biopharmaceutical company that previously advanced novel therapeutics to transform the care of serious diseases. We focused on…View ↗
Loading...
